Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 10mg | $30.00 | $3.00/mg | In stock | Jul 8 |
| vial | 20mg | $55.00 | $2.75/mg | Out of stock | Jul 8 |
| vial | 30mg | $120.00 | $4.00/mg | Out of stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. BPC-157 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does NG Peptide sell BPC-157?
Yes — NG Peptide currently lists BPC-157 in 3 variants starting at $55.00 ($2.75/mg).
Is NG Peptide's BPC-157 third-party tested?
Yes — Disclosed Labs has indexed 6 Certificates of Analysis for NG Peptide's BPC-157, with the most recent showing 100.0% purity. NG Peptide holds an overall trust grade of B (85/100) across all 114 COAs on file.
What is NG Peptide's trust grade for BPC-157?
NG Peptide has an overall Disclosed Labs trust grade of B (85/100), computed from 114 COAs across all peptides. The most recent BPC-157 COA was issued by ILS Labs.
Where is the cheapest BPC-157?
As of the latest data, Alpha Peptides offers BPC-157 at $1.82/mg — compare with NG Peptide's listing at $2.75/mg. See the full BPC-157 price comparison.
Is BPC-157 legal to buy?
BPC-157 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| BC-01-LD | May 2026 | — | ILS Labs | Endotoxin, Sterility, Heavy metals | Confirmed1 flag | View |
| BC10-07 | May 2026 | 99.3% | ILS Labs | Endotoxin, Sterility, Heavy metals | Confirmed1 flag | View |
| BC1527 | Jan 2026 | 99.8% | Janoshik Analytical | — | Unverified | View |
| BC01 | Dec 2025 | — | Freedom Diagnostics | — | Unverified | View |
| BPC62 | Oct 2025 | 99.8% | BioRegen | — | Confirmed | View |
Disclosed Labs